참고문헌
- Agarwal A, Mehrotra PK, Jain M, et al (2010). Size of the tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): Can They Predict Malignancy? World J Surg, 34, 3022-8. https://doi.org/10.1007/s00268-010-0744-5
- Clarke MR, Weyant RJ, Watson CG, et al (1998). Prognostic markers in pheochromocytoma. Hum Pathol, 29, 522-6. https://doi.org/10.1016/S0046-8177(98)90070-3
- DeLellis RA, Lloyd RV, Heitz PU, et al (2004). World Health Organization Classification of Tumours Pathology & Genetics. Tumours of Endocrine Organs, 151-5.
- de Wailly P, Oragano L, Rade F, et al (2012). Malignant pheochromocytoma: new malignancy criteria. Langenbecks Arch Surg, 397, 239-46. https://doi.org/10.1007/s00423-011-0850-3
- Ernest E. Lack (2007). Tumors of the adrenal gland. In 'Diagnostic Histopathology of Tumors 3rd Edition', Eds Christopher D.M. Fletcher. Elsevier Ltd, Philadelphia pp 1109-15.
- Harrison LE, Gaudin PB, Brennan MF (1999). Pathologic features os prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg, 134, 181-5. https://doi.org/10.1001/archsurg.134.2.181
- Kimura N, Miura W, Noshiro T, et al (1994). Ki-67 is an indicator of progression in neuroendocrine tumours. Endocr Pathol, 5, 223-8. https://doi.org/10.1007/BF02921490
- Linnoila RI, Keiser HR, Steinberg SM, et al (1990). Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Patol, 21, 1168-80. https://doi.org/10.1016/0046-8177(90)90155-X
- Nagura S, Katoh R, Kawaoi A, et al (1999). Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas. Mod Pathol, 12, 1107-11.
- Rosai J (2011). Pheochromocytoma. In 'Surgical Pathology 10th Edition', Eds Rosai and Ackermans. MOSBY Elsevier Inc. pp 1076-8.
- Strong VE, Kennedy T, Al-Ahmadie H, et al (2008). Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery, 143, 759-68. https://doi.org/10.1016/j.surg.2008.02.007
- Szalat A, Fraenkel M, Doviner V, et al (2011). Malignant pheochromocytoma: Predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center. Endocrine, 39, 160-6. https://doi.org/10.1007/s12020-010-9422-5
- Thompson LD (2002). Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol, 26, 551-66. https://doi.org/10.1097/00000478-200205000-00002
- van der Harst E, Bruining HA, Jaap Bonjer H, et al (2000). Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? J Pathol, 191, 175-80. https://doi.org/10.1002/(SICI)1096-9896(200006)191:2<175::AID-PATH615>3.0.CO;2-Z
- Wu D, Tischler AS, Lloyd RV, et al (2009). Observer variation in the application of the pheochromocytoma of adrenal Gland Scaled Score. Am J Surg Pathol, 33, 599-608. https://doi.org/10.1097/PAS.0b013e318190d12e
피인용 문헌
- Prognostic Factors in Oligodendrogliomas: a Clinical Study of Twenty-Five Consecutive Patients vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5319
- Pheochromocytoma multisystem crisis treated with emergency surgery: a case report and literature review vol.8, pp.1, 2015, https://doi.org/10.1186/s13104-015-1738-z
- The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature vol.11, pp.2, 2019, https://doi.org/10.3390/cancers11020225